Figure 2.
Schematic overview of the leukotriene and prostanoid biosynthesis pathway. Arachidonic acid (AA) is released from cellular membranes by cytosolic phospholipase A2 (PLA2). The free AA can further be converted to different leukotrienes (LT). 5-LO is crucial for the conversion of AA to 5(S)-hydroperoxyeicosatetraenoic acid (5-HPETE) and LTA4. LTA4 is further converted to LTB4 by LTA4 hydrolase (LTA4H) or to the cysteinyl-containing LTC4 by LTC4 synthase (LTC4S), which can be metabolized to LTD4 and LTE4. Biosynthesis of prostanoids begins with the enzyme cyclooxygenase (COX)-1 or COX-2 converting AA to prostaglandin (PG) H2, which is further converted to a variety of other prostanoids. Thromboxane A2 (TXA2) is generated by TXA synthase (TXAS), while the synthases PGxS produce the certain PGs: PGF2α, PGI2, and PGD2. The microsomal PGE synthase-1 (mPGES-1) catalyzes formation of PGE2.